Figure S2 from PD-L1 Negative Status is Associated with Lower Mutation Burden, Differential Expression of Immune-Related Genes, and Worse Survival in Stage III Melanoma — Jason Madore (2023) | RDL Network
Figure S2 from PD-L1 Negative Status is Associated with Lower Mutation Burden, Differential Expression of Immune-Related Genes, and Worse Survival in Stage III Melanoma
Preprint 2023 en
Authors
JM
Jason Madore
DS
Dario Strbenac
RV
Ricardo E. Vilain
Abstract
1 min read
<p>PD-L1 and mutation burden in independent validation cohort (n = 16). Results are similar to those observed in the study cohort but not statistically significant (p = 0.12; Kruskal-Wallis).</p>
Jason Madore, Dario Strbenac, Ricardo E. Vilain, Alexander M. Menzies, Jeen Y. H. Yang, John F. Thompson, Georgina V. Long, Graham J. Mann, Richard A Scolyer, James S. Wilmott
Jason Madore, Dario Strbenac, Ricardo E. Vilain, Alexander M. Menzies, Jeen Y. H. Yang, John F. Thompson, Georgina V. Long, Graham J. Mann, Richard A Scolyer, James S. Wilmott
Jason Madore, Dario Strbenac, Ricardo E. Vilain, Alexander M. Menzies, Jeen Y. H. Yang, John F. Thompson, Georgina V. Long, Graham J. Mann, Richard A Scolyer, James S. Wilmott
Jason Madore, Dario Strbenac, Ricardo E. Vilain, Alexander M. Menzies, Jeen Y. H. Yang, John F. Thompson, Georgina V. Long, Graham J. Mann, Richard A Scolyer, James S. Wilmott
Jason Madore, Dario Strbenac, Ricardo E. Vilain, Alexander M. Menzies, Jeen Y. H. Yang, John F. Thompson, Georgina V. Long, Graham J. Mann, Richard A Scolyer, James S. Wilmott
Discussion(0)
No comments yet. Be the first to comment.